清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Three Artificial Liver Models of Treatment of Acute-on-Chronic Liver Failure

作者
Yanping Xiang,Renhua Li,Jia Xi Cai,Qian Jiang
出处
期刊:Therapeutics and Clinical Risk Management [Dove Medical Press]
卷期号:Volume 20: 731-740 被引量:9
标识
DOI:10.2147/tcrm.s485620
摘要

Background: This study aimed to investigate clinical efficacy, safety and short-term prognosis of plasma exchange (PE), plasma perfusion combining PE (PP+PE), dual-plasma molecular adsorption system combining PE (DPMAS+PE) in treating acute-on-chronic liver failure (ACLF). Methods: Two hundred and fourteen ACLF patients admitted to our hospital were included and divided into PE (n = 72), PP+PE (n = 75), DPMAS+PE group (n = 67). Laboratory indexes and MELD scores were collected, and clinical efficacy was compared. Patients’ adverse reactions during and 24-h after treatment were collected, and safety was compared. Survival status of patients was followed-up within 90 days, and prognosis was analyzed. Results: PE, PP+PE and DPMAS+PE significantly reduce TBiL, DBiL, ALT, AST, SA, PT, INR, PCT and CRP levels, and increase PA and PTA levels, compared with pre-treatments ( P < 0.05). WBC and SCR levels in DPMAS+PE group decreased significantly post-treatment ( P < 0.05). Na + and Cl − levels in PE and PP+PE group decreased significantly post-treatment ( P < 0.05). Total adverse reaction incidence in PE, PP+PE, DPMAS+PE group were 38.89%, 22.70%, 17.90%, respectively, with significant differences among three groups ( P < 0.05). Ninety-day mortality rates of patients in PE, PP+PE, DPMAS+PE group were 41.67%, 34.67%, 20.90%, respectively, with significant differences among three groups ( P < 0.05). Conclusion: PE, PP+PE and DPMAS+PE three artificial liver treatment modes can effectively improve liver, kidney and coagulation function of ACLF patients. DPMAS+PE demonstrated better ability to remove endotoxin and inflammatory mediators, showed advantages in reducing ACLF patient mortality within 90 days, and had the least impact on electrolyte post-treatment. Therefore, DPMAS+PE can be used as a better choice for clinical treatment. Keywords: artificial liver treatment mode, acute-on-chronic liver failure, plasma exchange, plasma perfusion, double plasma molecular adsorption system
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
4秒前
龙龙发布了新的文献求助10
5秒前
成就马里奥完成签到,获得积分10
5秒前
顺利大门完成签到,获得积分10
26秒前
31秒前
超帅黑夜完成签到,获得积分10
37秒前
科研通AI6.3的应助被Raju采纳,获得10
38秒前
爱撒娇的芷巧完成签到,获得积分10
38秒前
aspect完成签到 ,获得积分10
40秒前
jane123完成签到,获得积分10
41秒前
50秒前
龙龙发布了新的文献求助10
51秒前
Everything完成签到,获得积分10
57秒前
1分钟前
健康的忘幽完成签到,获得积分10
1分钟前
田様的应助被李pp采纳,获得10
1分钟前
1分钟前
1分钟前
孤独君浩发布了新的文献求助10
1分钟前
所所的应助被孤独君浩采纳,获得10
1分钟前
Criminology34的应助被科研通管家采纳,获得10
1分钟前
Criminology34的应助被科研通管家采纳,获得10
1分钟前
Criminology34的应助被科研通管家采纳,获得10
1分钟前
迷路飞凤完成签到,获得积分10
1分钟前
科研通AI6.2的应助被龙龙采纳,获得10
1分钟前
cc完成签到,获得积分10
1分钟前
1分钟前
合不着完成签到 ,获得积分10
1分钟前
loii完成签到,获得积分0
1分钟前
碧蓝山灵完成签到,获得积分10
1分钟前
池雨完成签到 ,获得积分10
1分钟前
2分钟前
2分钟前
2分钟前
2分钟前
tlh完成签到 ,获得积分10
2分钟前
2分钟前
诚心荟完成签到,获得积分10
2分钟前
甜美梦之完成签到,获得积分10
2分钟前
曾经的冰安完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173194
求助须知:如何正确求助?哪些是违规求助? 9565558
关于积分的说明 21780461
捐赠科研通 7767279
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476682